Mukaltin (Mucaltin)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For 1 tablet:

Althea medicinal herb extract (mucaltin) 0.05 g;

Auxiliary substances: sodium hydrogen carbonate 0.087 g; tartaric acid 0.16 g; calcium stearate 0.003 g.

Description:

Tablets from light gray to brownish-gray color, with impregnations of a lighter and darker color, with a specific odor.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
    • Pharmacodynamics:

    Mukaltin is a mixture of polysaccharides from the herb althea medicinal, possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of bronchial glands.

    Pharmacokinetics:No data available.
    Indications:

    Acute and chronic diseases of the lower respiratory tract, accompanied by the formation of hard-to-detachable sputum of increased viscosity (including tracheobronchitis, obstructive bronchitis, pneumonia, bronchiectasis) - as part of complex therapy.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - peptic ulcer of the stomach and duodenum;

    - children's age (up to 12 years).

    Pregnancy and lactation:

    The use of the drug during pregnancy and during breastfeeding is possible on the advice of a doctor.

    Dosing and Administration:

    Inside before eating.

    Adults and children from the age of 12: 1-2 tablets 2-3 times a day.

    Children can dissolve the pill in 1/3 cup of warm water.

    Course of treatment on average 7-14 days

    Side effects:

    Allergic reactions.

    From the gastrointestinal tract: rarely - dyspeptic phenomena.

    Overdose:

    Until now, no cases of overdose with the use of the drug have been reported.

    Interaction:

    Mukaltin can prescribe simultaneously with other drugs used in the treatment of bronchopulmonary diseases.

    Mukaltin do not do it apply simultaneously with preparations containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:

    Tablets, 50 mg.

    Packaging:

    For 10 tablets in a contour mesh package from the film tolivinisLchloride and aluminum foil printed lacquered or paper with a polymer coating.

    For 10 tablets in a contour non-cellular package of paper with a polymer coating.

    By 1, 2, 3, 5 or 10 contour mesh or cell-free packages together with the instructions for use are placed in a pack of cardboard.

    It is allowed to place contiguous cell or non-cellular packages together with an equal number of instructions for use in group packaging.

    Storage conditions:

    In a dry place, at a temperature not exceeding 15 ° ะก.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:P N003415 / 01
    Date of registration:16.08.2011
    Expiration Date:Unlimited
    The owner of the registration certificate:MEDISORB, CJSC MEDISORB, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.05.2018
    Illustrated instructions
      Instructions
      Up